# EpiCor Clinical Study on Rapid Immune Modulating Effects

> **NCT05819424** · NA · COMPLETED · sponsor: **Cargill** · enrollment: 30 (actual)

## Conditions studied

- Immune Surveillance

## Interventions

- **DIETARY_SUPPLEMENT:** Yeast Fermentate (EpiCor)

## Key facts

- **NCT ID:** NCT05819424
- **Lead sponsor:** Cargill
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-16
- **Primary completion:** 2023-11-16
- **Final completion:** 2023-11-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05819424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05819424, "EpiCor Clinical Study on Rapid Immune Modulating Effects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05819424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*